Cleared Traditional

K053327 - OXICOM CONTROL

K053327 is the FDA 510(k) clearance for OXICOM CONTROL by Bionostics, Inc.. It is a Class 1 Chemistry device (product code JJX) cleared through the Traditional 510(k) pathway after a 56-day FDA review.

K053327 · Bionostics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2006
Decision
56d
Days
Class 1
Risk

K053327 is an FDA 510(k) clearance for the OXICOM CONTROL. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Bionostics, Inc. (Devens, US). The FDA issued a Cleared decision on January 26, 2006 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bionostics, Inc. devices

Submission Details

510(k) Number K053327 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 01, 2005
Decision Date January 26, 2006
Days to Decision 56 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 88d · This submission: 56d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 274
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K053327.
ELECSYS ANTI-TSHR CALCHECK
K080643 · Roche Diagnostics · Aug 2008
ELECSYS PROBNP II CALCHECK
K080147 · Roche Diagnostics Corp. · Feb 2008
PRECINORM CK-MB AND PRECIPATH CK-MB CONTROLS
K062972 · Roche Diagnostics Corp. · Oct 2006
ROCHE DIAGNOSTICS ELECSYS PROLACTIN II CALCHECK
K053059 · Roche Diagnostics · Nov 2005
LIQUICHEK BNP CONTROL
K043584 · Bio-Rad Laboratories, Inc. · Feb 2005
MODIFICATION TO ROCHE ELECSYS FOLATE II CALCHECK II
K043320 · Roche Diagnostics Corp. · Dec 2004